Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: EXACT Therapeutics

Market Cap 53.46M 5.63M 4.87M 4.48M 4.2M 7.86M 535M 7.99M 52.94M 20.64M 261M 21.14M 20.69M 902M P/E Ratio 2024
-2.49x
P/E Ratio 2025 -1x
Enterprise Value 29.55M 3.11M 2.69M 2.48M 2.32M 4.35M 296M 4.41M 29.26M 11.41M 144M 11.68M 11.44M 499M EV / Sales 2024
-
EV / Sales 2025 1,074,437,000x
Free-Float
30.97%
Yield 2024 *
-
Yield 2025 -
1 day-7.69%
1 week-7.14%
Current month-10.34%
1 month-39.53%
3 months-70.23%
6 months-41.35%
Current year-43.48%
1 week 0.58
Extreme 0.58
0.93
1 month 0.58
Extreme 0.58
1.56
Current year 0.58
Extreme 0.58
2.7
1 year 0.58
Extreme 0.58
3
3 years 0.58
Extreme 0.58
20
5 years 0.58
Extreme 0.58
26
10 years 0.58
Extreme 0.58
53.59
Manager TitleAgeSince
Chief Executive Officer 66 2022-06-05
Chief Operating Officer - 2011-12-31
Director of Finance/CFO - 2022-09-30
Director TitleAgeSince
Chairman 55 2018-06-21
Chairman - 2022-06-07
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap.
23-01-03Buy

Founder

2,500 0.0083%
23-01-03Buy

Chief Technology Officer

2,500 0.0083%
23-01-03Buy

Chairman

2,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
-7.69%-7.14%-72.92%-93.50% 5.63M
+0.96%+1.16%-12.70%-12.33% 43.03B
+3.18%+6.78%+298.69%+530.71% 32.71B
-1.69%-2.62%+12.32%-17.49% 30.29B
+0.71%-1.55%+0.83%+32.62% 29.4B
+1.16%+2.10%+14.27%+22.05% 25.08B
+2.26%+8.58% - - 13.54B
-0.27%+2.38%+55.76%+112.51% 13.35B
-1.09%-2.31%+3.49%+5.00% 12.97B
+0.20%+0.01%+108.70%+76.41% 12.11B
Average -0.18%+1.94%+45.38%+72.89% 21.25B
Weighted average by Cap. +0.77%+0.82%+60.75%+102.06%

Financials

2024 2025
Net sales - 0.06 0.01 0.01 0 0 0.01 0.59 0.01 0.06 0.02 0.29 0.02 0.02 1
Net income -52.33M -5.51M -4.76M -4.39M -4.11M -7.7M -524M -7.82M -51.82M -20.21M -255M -20.7M -20.25M -883M -86.97M -9.16M -7.91M -7.29M -6.83M -12.79M -871M -12.99M -86.12M -33.58M -424M -34.39M -33.66M -1.47B
Net Debt -98.89M -10.42M -9M -8.29M -7.76M -14.55M -990M -14.77M -97.93M -38.18M -482M -39.11M -38.27M -1.67B -23.91M -2.52M -2.18M -2.01M -1.88M -3.52M -239M -3.57M -23.68M -9.23M -117M -9.46M -9.25M -404M
Logo EXACT Therapeutics
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Employees
11
Date Price Change Volume
26-06-15 0.7800 kr -7.69% 116,017
26-06-12 0.8450 kr +19.01% 153,619
26-06-11 0.7100 kr -14.97% 22,010
26-06-10 0.8350 kr 0.00% 0
26-06-09 0.8350 kr -0.60% 80,791
  1. Stock Market
  2. Stocks
  3. EXTX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!